Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin Extended Release in Painful Diabetic Peripheral Neuropathy
NCT00712439Phase 2Completed
- Sponsor
- Assertio
- Start
- Apr 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gabapentin in diabetic peripheral neuropathy (DPN), sponsored by Assertio. Started Apr 2006; status: completed.
02
Drugs
gabapentin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00712439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712439.